BTMD biote Corp

USD 8.03 0.20 2.554278
Icon

biote Corp (BTMD) Stock Analysis and Price Targets

COMMON STOCK | Medical Care Facilities | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Bullish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 8.03

+0.20 (+2.55)%

USD 0.50B

0.22M

USD 7.61(-5.23%)

USD 6.00 (-25.28%)

Icon

BTMD

biote Corp (USD)
COMMON STOCK | NSD
USD 8.03
0.00 0
Take a Tour
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Bullish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 0.50B

USD 6.00 (-25.28%)

USD 8.03

biote Corp (BTMD) Stock Forecast

Show ratings and price targets of :
USD 7.61
(-5.23%)

Based on the biote Corp stock forecast from 3 analysts, the average analyst target price for biote Corp is USD 7.61 over the next 12 months. biote Corp’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of biote Corp is Bullish , which is based on 10 positive signals and 4 negative signals. At the last closing, biote Corp’s stock price was USD 8.03. biote Corp’s stock price has changed by -2.19% over the past week, +10.00% over the past month and +8.22% over the last year.

No recent analyst target price found for biote Corp
No recent average analyst rating found for biote Corp

Company Overview biote Corp

biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance. The company offer...Read More

https://biote.com

1875 W. Walnut Hill Ln #100, Irving, TX, United States, 75038

194

December

USD

USA

Adjusted Closing Price for biote Corp (BTMD)

Loading...

Unadjusted Closing Price for biote Corp (BTMD)

Loading...

Share Trading Volume for biote Corp Shares

Loading...

Compare Performance of biote Corp Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for BTMD

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To biote Corp (Sector: Medical Care Facilities )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
ENSG
The Ensign Group Inc +0.44 (+0.32%) USD7.65B 35.44 23.03

ETFs Containing BTMD

Symbol Name BTMD's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About biote Corp (BTMD) Stock

Based on ratings from 3 analysts biote Corp's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Bullish . The stock has 3 buy, sell and hold ratings.

Unfortunately we do not have enough data on BTMD's stock to indicate if its a good dividend stock.

Based on targets from 3 analysts, the average taret price for BTMD is USD 7.61 over the next 12 months. The maximum analyst target price is USD 9 while the minimum anlayst target price is USD 5.59.

BTMD stock's Price/Earning ratio is 17.61. Our analysis grades BTMD stock's Price / Earning ratio at C+. This means that BTMD stock's Price/Earning ratio is above 21% of the stocks in the Medical Care Facilities sector in the NSD exchange. Based on this BTMD may be undervalued for its sector.

The last closing price of BTMD's stock was USD 8.03.

The most recent market capitalization for BTMD is USD 0.50B.

Based on targets from 3 analysts, the average taret price for BTMD is projected at USD 7.61 over the next 12 months. This means that BTMD's stock price may go down by -5.23% over the next 12 months.

We can't find any ETFs which contains biote Corp's stock.

As per our most recent records biote Corp has 194 Employees.

biote Corp's registered address is 1875 W. Walnut Hill Ln #100, Irving, TX, United States, 75038. You can get more information about it from biote Corp's website at https://biote.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...